TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
INKT

Mink Therapeutics Inc

Healthcare · Biotechnology

12.30$ +1.2% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INKT
Line item 2019 2020 2021 2022 2023 2024 2025
– +248.0% +783.4% -46.6% -78.8% +25.7% +148.9%
– +287.4% +1,014.0% -48.5% -82.4% +38.6% +177.6%
– +799.9% +1,345.1% -49.5% -82.9% +35.9% +191.9%
– +799.9% +1,345.1% -49.5% -82.9% +35.9% +191.9%
– -51.7% -90.9% – – – –
– +1,075.7% -99.8% – – – –
– +17.4% +32.3% +75.9% – – –
– +55.2% -71.8% +32.8% +3.4% +11.9% +12.5%
– +91.7% +15.8% -23.0% -10.1% -39.0% +87.2%
– – – – – – –
– +27.9% -4.7% +94.4% -32.8% -30.3% +25.6%
– +63.6% – – – – –
– – – -101.7% – – –
– – – – – – –
– +37.4% +1.2% +0.6% +2.0% +12.4% +10.5%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?